comparemela.com

Latest Breaking News On - Claire parisel - Page 1 : comparemela.com

THERYQ; Gustave Roussy: THERYQ and Gustave Roussy have been selected as part of the i-Démo France 2030 call for projects, operated on behalf of the French government by Bpifrance, for the FLASHDEEP project, for an amount of 38 million euros

THERYQ; Gustave Roussy: THERYQ and Gustave Roussy have been selected as part of the i-Démo France 2030 call for projects, operated on behalf of the French government by Bpifrance, for the FLASHDEEP project, for an amount of 38 million euros
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France

Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

SEngine Precision Medicine and Gustave Roussy Announce Plan

Gustave Roussy joins the WIN Consortium in personalized cancer medicine

 E-Mail By joining the global network of WIN, Gustave Roussy is expecting to increase its global impact and to help improve cancer outcomes across the world, said Prof. Jean-Charles Soria, General Director of Gustave Roussy. We are very proud to welcome Gustave Roussy back to WIN, said Dr. Richard L Schilsky, Chairman of WIN, and past ASCO Executive Vice President and Chief Medical Officer (2013-2021), Gustave Roussy is a leader among European cancer research centres with remarkable research, talented faculty and innovative leadership and will be a major asset for WIN. As a founding member of WIN, Gustave Roussy contributed to the vision and facilitated the launch of a global precision cancer medicine consortium that has come to fruition in WIN. We are delighted that they are returning to the Consortium at a pivotal time in its history.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.